Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (13)
P 4 (2)

Trial Status

Recruiting6
Not Yet Recruiting5
Unknown5
Completed4
Active Not Recruiting3

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT07566624Not Yet RecruitingPrimary

Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation

NCT06510855Not ApplicableActive Not Recruiting

DurAVR™ THV EU-EFS

NCT07545369Not ApplicableNot Yet RecruitingPrimary

ULTRA-EVOLUT RCT: A Comparison of Latest-Generation TAVR Valves

NCT05712161Not ApplicableActive Not Recruiting

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study

NCT07456280Not ApplicableNot Yet RecruitingPrimary

Evaluation of the Non-invasive Electrocardiographic Monitoring Strategy Associated With Early Discharge in Patients With Conduction Disorder Through TAVI Implantation

NCT07335900Not ApplicableRecruitingPrimary

A Clinical Study Using FAPI-PET Imaging to Assess the Postoperative Effects of TAVI in Patients With Aortic Stenosis

NCT05873816Not ApplicableCompletedPrimary

The PROTEMBO Trial

NCT05847751Active Not RecruitingPrimary

The Use of ACURATE Neo 2 Valve in Patients With Symptomatic Aortic Valve Stenosis

NCT06156592CompletedPrimary

Post Spinal Hemodynamic Changes in Aortic Stenosis and Mitral Regurgitation by VIS Index and Echocardiography

NCT05552352Not ApplicableRecruitingPrimary

VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease

NCT07108478Not Yet RecruitingPrimary

A Prospective, Multicenter, Observational Study of the Safety and Efficacy of Emergency Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis

NCT06917066RecruitingPrimary

MYLEAD Spanish Prospective Registry

NCT06859255Not ApplicableRecruitingPrimary

In-vitro Benchmarking of Currently Available Heart Valve Prostheses for Surgical and Percutaneous Treatment of Aortic Stenosis With Small Annulus, Followed by In-vivo Validation

NCT06168123RecruitingPrimary

Future Optimal Research and Care Evaluation - Aortic Stenosis

NCT06168370Not ApplicableRecruitingPrimary

Personalized, CT-guided Antithrombotic Therapy Versus Lifelong Single Antiplatelet Therapy to Reduce Thromboembolic and Bleeding Events in Non-atrial Fibrillation Patients After Transcatheter Aortic Valve Implantation

NCT05182307Not ApplicableUnknown

DurAVR™ THV System: First-In-Human Study

NCT05097183UnknownPrimary

Validation of Accurate Commissural Alignment During Transcatheter Aortic Valve Implantation

NCT05283356Phase 4UnknownPrimary

Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation

NCT05024942Unknown

LUS in Aortic Stenosis Patients Undergoing TAVR

NCT04988243Not ApplicableNot Yet RecruitingPrimary

Multi Center Registry of Transcatheter Aortic Valve Replacement in Northeast China

Scroll to load more

Research Network

Activity Timeline